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Abstract
Introduction: Pneumonia and diarrhoea disproportionately affect children in resource-poor settings. Integrated
community case management (iCCM) involves community health workers treating diarrhoea, pneumonia and
malaria. Studies on impact of iCCM on appropriate treatment and its effects on equity in access to the same are
limited. The objective of this study was to measure the impact of integrated community case management (iCCM)
as the first point of care on uptake of appropriate treatment for children with a classification of pneumonia
(cough and fast breathing) and/or diarrhoea and to measure the magnitude and distribution of socioeconomic
status related inequality in use of iCCM.
Methods: Following introduction of iCCM, data from cross-sectional household surveys were examined for
socioeconomic inequalities in uptake of treatment and use of iCCM among children with a classification of
pneumonia or diarrhoea using the Erreygers’ corrected concentration index (CCI). Propensity score matching
methods were used to estimate the average treatment effects on the treated (ATT) for children treated under the
iCCM programme with recommended antibiotics for pneumonia, and ORS plus or minus zinc for diarrhoea.
Findings: Overall, more children treated under iCCM received appropriate antibiotics for pneumonia (ATT = 34.7 %,
p < 0.001) and ORS for diarrhoea (ATT = 41.2 %, p < 0.001) compared to children not attending iCCM. No such increase
was observed for children receiving ORS-zinc combination (ATT = -0.145, p < 0.05).
There were no obvious inequalities in the uptake of appropriate treatment for pneumonia among the poorest and least
poor (CCI = -0.070; SE = 0.083). Receiving ORS for diarrhoea was more prevalent among the least poor groups (CCI = 0.199;
SE = 0.118). The use of iCCM for pneumonia was more prevalent among the poorest groups (CCI = -0.099; SE = 0.073). The
use of iCCM for diarrhoea was not significantly different among the poorest and least poor (CCI = -0.073; SE = 0.085).
Conclusion: iCCM is a potentially equitable strategy that significantly increased the uptake of appropriate antibiotic
treatment for pneumonia and ORS for diarrhoea, but not the uptake of zinc for diarrhoea. For maximum impact,
interventions increasing zinc uptake should be considered when scaling up iCCM programmes.
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Introduction
Pneumonia and diarrhoea disproportionately affect children
living in low-income countries. While there is evidence on
effectiveness of community based delivery of treatment of
pneumonia and diarrhoea [1–3], slow progress in coverage
of these interventions has been noted over the last ten years
[4–7]. Of critical importance is the extremely low coverage
of oral rehydration salts (ORS) and zinc for the treatment
of diarrhoea, despite their proven effectiveness [3, 8]. As a
vehicle to increase coverage of lifesaving treatment for
children suffering from these three child killers, a joint
statement was produced by the World Health Organisation
(WHO) and United Nations Children's Fund (UNICEF) in
2004 calling for integrated community case management
(iCCM) of pneumonia and diarrhoea in addition to malaria
in countries where these diseases are common [9]. Uganda
was one of the first countries to respond to this call by
formulating a national iCCM policy in 2010.
iCCM is now an increasingly common approach to
tackling these diseases in Sub-Saharan Africa [1, 6, 9]. With
respect to pneumonia, studies have previously estimated
that community case management (CCM) has the potential
to cause a 70 % reduction in mortality among children aged
five years and below [10]. It is also postulated that CCM for
pneumonia may lower drug resistance through improved
social inclusion and rational drug use using the WHO
approved classification and treatment algorithm [10, 11].
Despite these postulations, the introduction of antibiotics at
the community level in African contexts has been criticised
in some literature [12].
However, with the introduction of new health care
interventions comes the risk of inequities in access to
care for the poorest households [13, 14]. iCCM is inher-
ently designed to improve access to health care for
children in the poorest families but there is paucity of
data on how iCCM has impacted on equity in access to
appropriate treatment for diarrhoea and pneumonia.
This study aimed to evaluate both equity in use of iCCM
and its impact on uptake of appropriate treatments for




The study was conducted in nine predominantly rural dis-
tricts in Midwestern Uganda where the iCCM programme
had been implemented by Malaria Consortium in collabor-
ation with the Ministry of Health since 2010. The districts
had an estimated population of 2.2 million inhabitants and
approximately 23.3 % were children below the age of five
years. By 2012 approximately 6800 community health
workers (CHWs) were trained to deliver iCCM in the area.
The CHWs complemented the formal healthcare sector in
an area where health markets for children range from
informal care at home and in the private sector to formal
care from often distant and poorly functional health facil-
ities. More than half of children being taken for care out-
side the home in Uganda are known to go to a drug shop
or private clinic [15].
In Uganda, CHWs working from home, locally known
as village health team (VHT) members are an important
and integral part of the healthcare system and represent the
lowest health centre level offering promotive, preventive,
and curative health services. In a typical village, there is a
team of five to six CHWs offering a package of promotive
and preventive health services, with two of them trained on
iCCM for a duration of six days. Curative services offered
under iCCM include provision of colour-coded artemether/
lumefantrine combination to children aged 4–59 months
confirmed to have uncomplicated malaria through a rapid
diagnostic test, colour-coded amoxicillin to children aged
2–59 months with pneumonia classification based on
cough and fast breathing, and zinc and ORS to children
aged 2–59 months with uncomplicated diarrhoea. Children
showing danger signs are referred to the nearest health fa-
cility, from which the CHWs receive supervision. In 2009
the recommended first-line antibiotic treatment for pneu-
monia was trimethoprim-sulfamethoxazole, while that for
diarrhoea was ORS. Following a policy change in 2010,
treatment guidelines changed to amoxicillin, and ORS-zinc
combination for pneumonia and diarrhoea, respectively.
Study design and participants
The outcome of interest in this study was receiving
appropriate treatment for either pneumonia or diarrhoea
and has been defined as a) a child receiving an appropri-
ate antibiotic for pneumonia if he or she is reported to have
had cough and fast breathing (fast breathing pneumonia)
and b) a child receiving either ORS alone or a combination
of ORS and zinc if he or she is reported to have had watery
stools or abnormally frequent bowel motions. The exposure
variable of interest in this study has been defined as obtain-
ing treatment from a community health worker (CHW)
delivering iCCM services.
In order to obtain data on the outcome and exposure
variable of interest, the study draws from before (2009)
and after (2012) population based household surveys. The
surveys sought to a) evaluate effect of iCCM on the
proportion of children with access to appropriate care for
fever, diarrhoea and fast breathing pneumonia through
assessment of caregivers health-seeking behaviour around
the illnesses, and b) provide an indirect estimate of infant
and under-five mortality before and after implementation
of iCCM compared to control areas (data not presented in
this paper but elsewhere [16]). With respect to health
seeking behaviour, the surveys employed a facilitator-
administered a questionnaire that asked about the symp-
toms experienced by eligible children, having sought for
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health care from outside the home, places from which
health care was sought and any treatments obtained. The
treatments obtained, when necessary were identified by
the facilitators through examination of drug leftovers,
prescription notes and with the use of ‘Drug cards’, which
were a collection of pictures of common medicines cre-
ated to assist caretakers in the identification of treatments
provided for their children.
Study participants included primary caregivers of
under-fives to whom the adapted questionnaire was
administered. The sample size was therefore calculated
based on a population-based, representative household
interview survey for children under five, with a primary
sample of 100 clusters for which household and birth
history data were collected, and a smaller, nested sample
of 40 clusters for the health-seeking behaviour compo-
nent. Participant sampling was done with two-stage
cluster sampling using the census database of the
respective districts as a sampling frame, without restric-
tion or exclusion. The primary sampling units were
enumeration areas (village or cluster of household),
which were selected with probability proportionate to size.
First, the total sample needed for mortality estimation was
drawn jointly with the Uganda Bureau of Statistics
(UBOS) followed by a sub-set of clusters selected with
equal probability, which were used for the health-seeking
behaviour assessment. In the second stage of sampling, all
households in the selected villages were listed and the
number of households needed was selected by systematic
sampling. For villages with more than 200 households, an
equal size section approach was used whereby the village
was divided into 2-4 sections with an approximately equal
number of households, and one of the sections was
selected using simple random sampling.
Data analysis
The analysis in this paper is limited to the children aged
2–59 months whose primary caretakers were inter-
viewed for health-seeking practices from the nested 40
clusters at baseline (2009) and after implementation of
iCCM (2012). The data obtained in 2012 were used to
assess equity in use of iCCM among children with a
classification of pneumonia or diarrhoea and to evaluate
the impact of iCCM on uptake of appropriate treatment
for diarrhoea and pneumonia. Additionally, data ob-
tained in 2009 were used for complementary descriptive
analysis using before and after comparisons. The impact
of iCCM on treatment uptake was evaluated using pro-
pensity score matching methods (PSM). Therefore, the
sample size for impact evaluation included only matched
samples in the region of common support described
further in the analysis section [17, 18]. Figure 1 summa-
rises how the sample size for this study was derived.
Ethical considerations
Ethical approval for the study was obtained from the
Uganda National Council of Science and Technology
(HS 666). Written informed consent was obtained from
all the study participants.
Statistical analysis
The main objectives of the analysis were to measure the
impact of iCCM on uptake of appropriate treatments for
pneumonia and diarrhoea, and to measure the magnitude
and distribution of socioeconomic inequality in use of
iCCM. Uptake was defined as the proportion of children
eligible for treatment who were reported to have received
treatment. Children were eligible for pneumonia treat-
ment if they were reported to have had cough and fast
breathing while for diarrhoea it was children reported to
have had watery stools or abnormally frequent bowel
motions. Appropriate treatment for pneumonia comprised
of child receiving any antibiotic that was recommended as
a first line treatment according to Uganda’s treatment
guidelines or iCCM protocol [19]. Similarly the national
treatment guidelines and iCCM protocol recommend
ORS and Zinc for diarrhoea and therefore appropriate
treatment for diarrhoea comprised of ORS or a combin-
ation of ORS and zinc. For the uptake analysis, only the
first source of health care from which the child’s caregiver
sought for treatment outside the home was considered.
Differences in the proportions of children treated appro-
priately at different time points and between the different
groups were determined using Chi-square (χ2) tests. The
study probed for inequalities in both the disease preva-
lence and reception of appropriate. During the inequality
analysis, a socioeconomic status index was generated
through principle components analysis of household
assets and income generating activities that are recom-
mended by the Uganda Bureau of Statistics [20, 21]. The
variables used in the analysis included building materials
for the household, water source, type of toilet, type of fuel
used for cooking and occupation of the head of the house-
hold. The socioeconomic status index was then divided
into wealth quintiles. The individual indicators that
weighted heaviest in the analysis were house construction
materials. The socioeconomic status of the population
was ranked from poorest to least poor, and age-sex indir-
ectly standardized concentration indices (CI) were used to
measure socioeconomic related inequality in uptake of
antibiotics for pneumonia and ORS and zinc for diar-
rhoea. The CI is a measure of socioeconomic related
inequality, which takes on values between -1 and +1. In
the absence of inequalities, the concentration index takes
on the value of zero. Positive values of the CI imply that a
situation disproportionately affects the richer groups and
negative values imply that a situation affects the poorer
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groups more and the larger the value, the larger the
degree of inequality. Since receiving appropriate treatment
and using iCCM are both binary variables, the corrected
version of the CI, known as Erreygers concentration index
(CCI) recommended for bound outcomes, was computed
together with its standard error [22, 23]. The index is
denoted as:
CCI yð Þ ¼ 8cov yi;Rið Þ ð1Þ
where Yi = binary outcome and Ri = Fractional rank is
SES distribution. If inequality can be explained by linear
regression of K (justifiable standardising factors) and J
(non-justifiable inequality), this can be denoted as eq. (2)







then equation (i) can be rewritten as equation (iii) to show
socioeconomic related inequality in uptake as expressed
as a weighted sum of inequalities in its determinants and
a residual term.
CCI yð Þ ¼ 4 Xk






With the means of k x and Zj denoted as ̄xk and zj
respectively, and their concentration indices denoted as
CI (Xk) and CI (Zj) respectively, where GCε is a residual
term, the contribution of each factor to the inequalities
can thus be established. Unfair inequality can thus be
measured by subtracting fair inequality from the cor-
rected concentration index to give an index of horizontal
inequity (I) [24].
I ¼ CCI yð Þ‐4
Xk
k¼1βk xkCI xkð Þ
Due to the binary nature of the outcome variables,
unjustifiable inequality was estimated through a linear
model. Justifiable causes introduced in the model in-
cluded: age and sex while non-justifiable causes included
socioeconomic status, source of care, urban-location, edu-
cation level and occupation of caregivers. Horizontal in-
equity was only calculated for the variable use of iCCM
and not the variables relating to uptake of appropriate
treatment. This is because all children fitting the case
Fig. 1 Flow chart showing the breakdown of sample sizes for secondary data analysis for uptake of pneumonia and diarrhoea treatments
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definition would require treatment as per the treatment
guidelines. Therefore presence of any inequalities in treat-
ment uptake would be equated to inequity.
In order to assess the effect of iCCM on appropriate
treatment for pneumonia and diarrhoea, logistic regres-
sion models followed by PSM models were applied to the
2012 survey data for health seeking behaviour. The logistic
regression models were used to estimate the marginal
impact of exposure to iCCM on appropriate treatment for
pneumonia and diarrhea while controlling for observed
covariates. Despite their ability to account for possible
confounders, logistic regression models are prone to the
risk of selection bias. Since children exposed to iCCM
may differ from those exposed elsewhere in several ways
that can also influence uptake of appropriate treatment.
PSM models were therefore constructed to eliminate the
risk of selection bias. The propensity score generated by
PSM methods is a balancing score that is believed to
imitate a randomised controlled trial by generating a
control and treatment group known as the ‘treated’ and
‘control’ respectively. This is because systematic differ-
ences in the characteristics of individuals who choose to
participate or not to participate in a programme are
removed [25, 26]. Rosenbaum (1983) showed that if one
conditions on the probability that a person participates in
a programme (which is iCCM in this case), based on a set
observable characteristics (X) that influence programme
participation (P), known as the “propensity score (Pr(X) =
Probability (P =1| X))”, this person’s participation decision
(P) is also independent of the potential outcomes E(Y1
and Y0) where Y1 is the expected outcome in the presence
of the intervention and Y0 is the expected outcome in the
absence of the intervention [25, 26]. Propensity scores are
predicted probabilities, which have a continuous range
known as “support” between 0 and 1 and thus the match-
ing is done based on some intervals of this “support”, such
as (0,0.1), (0.1,0.2) for individuals whose propensity score
lies within the “common support”. The average treatment
effects on the treated (ATT) is the mean of individual
differences between the outcome of individual participants
and their matched pairs and are denoted as E[Y1 – Y0| X,
P = 1].
In this paper, the impact evaluation section refers to
children who sought for care from a CHW for diarrhoea
or pneumonia (used iCCM) as the ‘treated group’ and
those who sought care from elsewhere as the ‘control
group’. Therefore the term average treatment effects on
the treated (ATT) has been used to refer to the effect of
iCCM on appropriate treatment for pneumonia or
diarrhoea.
The covariates (observable variables) included in the
final PSM models included child’s age, sex of the respond-
ent, education level of primary caretaker, socioeconomic
status, concurrent infection with fever or diarrhoea, living
in an peri-urban area, having no mode of transport at
home, knowledge that CHWs have medicines, knowledge
of danger signs for pneumonia, number of previous visits
to CHWs in the past 3 months, history of hospitalisation
in the last three months, and duration of illness. Logit
regression was used to predict the propensity score and
ATT for participation in iCCM were computed using
different PSM techniques including a) kernel matching
with bootstrap standard errors, STATA command attk b)
stratification on the propensity score matching, STATA
command atts c) nearest neighbour matching, STATA
command attnd and d) radius matching of propensity
scores within a calliper of 0.01, STATA command attr.
Further more, sensitivity analysis using Rosenbaum
bounds (mhbounds command in STATA) was conducted
on the consistently significant ATT results. The purpose
of the sensitivity analysis was to examine the robustness of
the ATT results to unobserved confounding variables. In
all of the analysis, sample weights were applied and cluster
robust standard errors are reported. All computations
were done in STATA 12 (College Station, TX).
Results
Overall, there was a significant increase in the proportion
of children treated appropriately for both pneumonia and
diarrhoea between 2009 and 2012 (Table 1). Pneumonia
cases treated with appropriate antibiotics increased signifi-
cantly from 55.9 % to 66.4 % (p = 0.005) and the propor-
tion of children receiving ORS for diarrhoea increased
significantly from 34.5 % to 51.1 % (p = 0.001). The
proportion receiving both ORS and zinc increased from
3.0 % to 11.8 % (p = 0.001). Table 2 shows the distribution
of the indirectly standardised mean of illness prevalence
and appropriate treatment across the wealth quintiles.
While reported pneumonia prevalence in 2009 was
not significantly different among the poorest and least
poor (CCI = 0.027; SE = 0.033), the prevalence in 2012
was higher among the least poor groups (CCI = 0.077;
SE = 0.033) (Table 3). The proportion of children receiv-
ing appropriate treatment for pneumonia in 2009 was
also more prevalent among the least poor (CCI = 0.152;
SE = 0.092). However the proportion of children receiv-
ing appropriate antibiotics was not significantly different
among the least poor and poorest in 2012 (CCI = 0.070;
SE = 0.083). Diarrhoea prevalence was more concen-
trated among the least poor in 2009 (CCI = 0.044; SE =
0.039) but not in 2012 (CCI = -0.007; SE = 0.033).
Additionally, receiving ORS for diarrhoea was more
prevalent among the least poor in 2009 (CCI = 0.151; SE
= 0.148) and was even increasingly more prevalent
among the least poor in 2012 (CCI = 0.199; SE = 0.118).
Zinc uptake in 2012 remained too low (11.8 %; 27/229)
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to provide a sample size large enough to warrant calcu-
lation of a concentration index.
There was no evidence of socioeconomic inequalities
in use of iCCM for children with reported fast-breathing
pneumonia (CCI = -0.099; SE = 0.073) . The use of iCCM
for children with supposed pneumonia seems to favour
the least poor with total horizontal inequity index of
-0.099. There was also no evidence of socioeconomic
inequalities in use of iCCM for children with reported
symptoms of diarrhoea (CCI = -0.073; SE = 0.085).
In the logistic regression models from which the marginal
effects were calculated, children seeing CHWs as the first
source of care were (42.2 % points, p < 0.0001) more likely
to receive appropriate antibiotics for pneumonia compared
to those who did not see a CHW. They were also (39.6 %
points, p < 0.0001) more likely to ORS for diarrhoea com-
pared to those who did not see a CHW. There was however
no difference in the proportion of children receiving ORS-
zinc combination between the treatment and control
groups (p = 0.340).
Propensity scores for 453 children with reported symp-
toms of pneumonia ranged from 0.11 to 0.83 with a mean
(SD) of 0.45 (0.17) (Fig. 2), and from 0.10 to 0.88 with a
mean (SD) of 0.41 (0.18) for 229 children with diarrhoea
(Fig. 3). Each estimator generated five subgroups in which
all covariates were balanced. The resulting matched
Table 1 Key indicators for disease prevalence and treatment for pneumonia and diarrhoea
Disease/treatment 2009 2012 Increase year on year percentage points p-value
N (1178) % N (1476) %
Two week prevalence of ‘fast-breathing’ pneumonia 263 22.3 % 453 30.7 % 8.4 0.000a
Two week prevalence of diarrhoea 168 14.6 % 229 15.6 % 1.0 0.470
‘Fast-breathing’ pneumonia treated with appropriate
antibiotics
147 55.9 % 301 66.4 % 10.5 0.000a
Diarrhoea treated with ORS 58 34.5 % 117 51.1 % 16.6 0.001a
Diarrhoea treated with ORS plus zinc 5 3.0 % 27 11.8 % 8.8 0.001a
Treatment First source of care 2012 p-value
iCCM n (%) Other n (%)
‘Fast-breathing’ pneumonia treated with appropriate
antibiotics (N = 453)
184 (85.6) 117 (49.2) 0.000a
Diarrhoea treated with ORS (N = 229) 65 (80.2) 52 (35.14) 0.000a
Diarrhoea treated with ORS plus zinc (N = 229) 22 (14.9) 5 (6.2) 0.056
aSignificant at 95 % level of significant
Table 2 Distribution of wealth and indirectly standardized mean outcome variables for disease prevalence and treatment across
wealth quintiles
Quintile Poorest Very poor Poor Less poor Least poor
Distribution of wealth 2009 0.155 0.208 0.191 0.195 0.251
Distribution of wealth 2012 0.237 0.223 0.201 0.223 0.237
Two week prevalence of ‘fast breathing’ pneumonia in 2009 0.238 0.186 0.170 0.225 0.265
‘Fast breathing’ pneumonia treated appropriately in 2009 0.405 0.608 0.543 0.580 0. 767
Two week prevalence of ‘fast breathing’ pneumonia in 2012 0.267 0.290 0.313 0.337 0.365
‘Fast breathing’ pneumonia treated appropriately in 2012 0.406 0.531 0.755 0.595 0.523
Two week prevalence of diarrhoea in 2009 0.193 0.119 0.118 0.246 0.194
Diarrhoea treated appropriately in 2009 0.305 0.332 0.178 0.395 0.529
Two week prevalence of diarrhoea in 2012 0.094 0.168 0.152 0.166 0.102
Diarrhoea treated appropriately in 2012 0.414 0.389 0.528 0.576 0.618
Children using iCCM for ‘fast breathing’ pneumonia (2012) 0.400 0.503 0.359 0.426 0.297
Children using iCCM for diarrhoea (2012) 0.327 0.270 0.159 0.374 0.182
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treatment and control groups did not differ significantly on
most covariates (Tables 4 and 5). On average, at a 5 %
significance level, using the Kernel matching method, more
children in the treatment (iCCM) group received appropri-
ate antibiotics for pneumonia (ATT= 32.7 %, p < 0.001)
and ORS for diarrhoea (ATT = 41.2 %, p < 0.001) compared
to the control group (Table 6). No such increase was
observed for children receiving ORS-zinc combination
(ATT= -0.14.5 %, p <0.05). These significant iCCM
programme effects were consistent across all matching
estimators for both the treatment of pneumonia with
appropriate antibiotics and treatment of diarrhoea with
ORS but not for diarrhoea treatment with ORS-zinc
combination (Table 6). The sensitivity analysis of the
Q_mh+ statistic, which adjusts the Mantel-Haenszel statis-
tic downward for positive unobserved selection bias and
the Q_mh- statistic, which adjusts the Mantel-Haenszel
statistic downward for negative unobserved selection bias,
are summarised in Table 7. The analysis shows that the
ATT for appropriate treatment for pneumonia would be
sensitive to bias that will increase the odds of exposure to
iCCM to five. The results for appropriate treatment for
diarrhoea with ORS would be sensitive to bias that would
quadruple the odds of exposure to iCCM.
Discussion
Results from this study point to overall improvement in
uptake of appropriate treatment for pneumonia and diar-
rhoea across all socioeconomic strata following introduc-
tion of iCCM. There were also no significant inequalities in
use of iCCM observed despite the common observation
that introduction of new interventions may worsen inequi-
ties in the short run [14, 27]. The occurrence of inequities
in access to treatment within rural communities that are
assumed to be uniformly poor has previously been ascer-
tained [28]. However, in this study no discrepancies were
observed among children from different socioeconomic
Table 3 Erreygers’ corrected concentration indices (CCI) for disease prevalence, treatment uptake and horizontal inequity index (I)
for the use of integrated community case management
Variable CCI 2009 Standard error (I) CCI 2012 Standard error (I)
‘Fast breathing’ pneumonia prevalence 0.027 0.033 0.077a 0.033 n/a
Overall antibiotic treatment 0.152 0.092 n/a −0.070 0.083 n/a
Use of iCCM for ‘fast breathing’ pneumonia n/a n/a n/a −0.099a 0.073 −0.099
Diarrhoea prevalence 0.044a 0.039 −0.007 0.026 n/a
Overall ORS treatment 0.151a 0.148 0.151 0.199a 0.118 n/a
Use of iCCM for diarrhoea n/a n/a n/a −0.073 0.085 −0.012
ORS & zincb n/a n/a n/a n/a n/a n/a
aSignificant value within 95 % confidence intervals
bExcluded because of insufficient sample size
0 .2 .4 .6 .8 1
Propensity Score
Untreated: Off support Untreated: On support
Treated
Fig. 2 Distribution of propensity scores among the treated (iCCM) group and control group for uptake of appropriate treatment for pneumonia
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groups who were eligible for treatment and who received it.
This might be due to presence of under and over reporting
of ill health by poorer and less poor groups, respectively,
leading to small or no socioeconomic inequalities being
observed [24]. While this is a potential bias it is unlikely to
be the case, given the nature of free treatment offered in
iCCM.
The use of ORS was more concentrated among the
least poor in 2009 who also seemed to carry more of the
diarrhoea burden at that time. However, as time pro-
gressed, the least poor groups were disproportionately
receiving more of the ORS for diarrhoea despite no
obvious inequalities in the prevalence of diarrhoea
among the groups. This could be due to the fact that
more of the poorest children with diarrhoea were
seeking for health care from outside the iCCM interven-
tion and were therefore unable to access ORS. This can be
seen in Fig. 1, which shows that more children (81 versus
148) with diarrhoea did not seek for health care from
CHWs.
There is a significant increase in the total number of
children classified, as pneumonia in 2012 however there
was no significant difference in the proportion of children
seeking for care from iCCM and elsewhere. This finding is
comparable to what has been observed in Sierra-Leone
[29] and could be due to the fact that introduction of the
iCCM programme raised awareness among community
members who were then more likely to report cough and
fast-breathing during an illness episode upon seeking
treatment from outside the home.
0 .2 .4 .6 .8
Propensity Score
Untreated: Off support Untreated: On support
Treated
Fig. 3 Distribution of propensity scores among the treated (iCCM) group and control group for uptake of appropriate treatment for diarrhoea










Age child 2.37 2.28 0.484 2.22 2.15 0.601
Sex caretaker 1.63 1.70 0.105 1.69 1.69 0.906
Children per household 2.00 2.02 0.824 2.06 2.04 0.82
Mother’s education 0.16 0.10 0.089 0.11 0.11 0.862
Household wealth −0.08 −0.44 0.02 −0.46 −0.40 0.698
Fever present 0.42 0.49 0.101 0.57 0.51 0.323
Diarrhoea present 0.20 0.23 0.356 0.28 0.25 0.62
Peri-urban location 2.75 2.83 0.145 2.85 2.87 0.793
No transport available at home 0.54 0.44 0.032 0.46 0.43 0.66
Aware that CHWs have drugs 1.74 1.34 0.018 1.41 1.25 0.237
Aware of pneumonia danger signs 0.12 0.16 0.151 0.13 0.16 0.441
Previous visits to CHWs 1.57 2.17 0.001 2.43 2.17 0.224
Number of previous hospitalisation 6.59 4.55 0.344 0.96 1.32 0.727
Duration of illness 6.89 5.61 0.071 5.68 5.56 0.772
N.B. The term treated in the table refers to children exposed to the iCCM programme
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There were highly significant iCCM programme effects
observed for uptake of both appropriate pneumonia and
diarrhoea treatment. More of the children with reported
pneumonia symptoms in the treatment group received an
appropriate antibiotic compared to the children in the
control group. There were also significantly more children
receiving ORS for diarrhoea in the treatment group com-
pared to the control group. However, zinc uptake remained
low and did not differ significantly between the treatment
and control groups. Although some authors have argued
that there is insufficient evidence on efficacy and effective-
ness of community management of pneumonia [12], the
data suggest that if the WHO-iCCM algorithm [30] could
be followed by CHWs, the implementation of iCCM alone
in this predominantly rural setting would lead to 32.7 %
increase in the number of children with pneumonia symp-
toms receiving appropriate antibiotics, and a 40.0 %
increase in the number of children with diarrhoea receiving
ORS. The high ORS uptake combined with low zinc uptake
highlights the need to explore the untapped strategy of co-
packaging ORS and zinc, which has proven to improve
uptake of diarrhoea treatment elsewhere [31].
Study limitations and methodological considerations
include reporting bias of symptoms by caregivers, leading
to pneumonia misclassification. Also, PSM is known to be
prone to bias arising from endogenous covariates and
model misspecification [25, 26]. However the use of PSM
in this analysis is justifiable as there was no CHW/iCCM
intervention (treatment group) at baseline. PSM is known
to be superior to traditional logistic regression models,










Age child 1.92 1.87 0.727 1.67 1.81 0.436
Sex caretaker 1.63 1.57 0.368 1.58 1.54 0.622
Children per household 2.01 2.04 0.856 1.92 2.09 0.216
Mother’s education 0.11 0.10 0.815 0.20 0.11 0.114
Household wealth −0.41 −0.68 0.147 −0.48 −0.69 0.32
Fever present 0.45 0.60 0.028 0.61 0.58 0.74
Cough + fast breathing present 0.38 0.49 0.091 0.46 0.47 0.87
Peri-urban location 2.76 2.78 0.783 2.51 2.81 0.005
No transport available at home 0.44 0.68 0.001 0.59 0.66 0.398
Aware that CHWs have drugs 1.59 1.26 0.11 1.44 1.20 0.262
Previous visits to CHW 1.89 2.32 0.122 2.69 2.34 0.265
Number of previous hospitalisation 6.24 1.41 0.084 0.28 0.20 0.542
Duration of illness 6.49 6.54 0.974 7.30 6.61 0.306
N.B. The term treated in the table refers to children exposed to the iCCM programme
Table 6 Average treatment effects on the treated (ATT) for appropriate treatment of diarrhoea and pneumonia







Kernel Received ORS for diarrhoea 74 111 0.412 0.076 5.398 < 0.001a
Received ORS & zinc for diarrhoea 74 111 −0.146 0.069 −2.112 < 0.05a
Nearest neighbour Received ORS for diarrhoea 74 44 0.419 0.110 3.820 < 0.001a
Received ORS & zinc for diarrhoea 74 44 −0.095 0.078 −1.042 > 0.05
Stratification Received ORS for diarrhoea 70 115 0.412 0.076 5.398 < 0.001a
Received ORS & zinc for diarrhoea 70 115 −0.130 0.058 −2.236 < 0.05a
Radius Received ORS for diarrhoea 63 89 0.442 0.076 5.812 < 0.001a
Received ORS & zinc for diarrhoea 63 89 −0.099 0.056 −1.883 > 0.05
Kernel Antibiotic for pneumonia 166 190 0.327 0.050 6.548 < 0.001a
Nearest neighbour Antibiotic for pneumonia 166 82 0.289 0.072 4.024 < 0.001a
Stratification Antibiotic for pneumonia 163 193 0.331 0.053 6.229 < 0.001a
Radius Antibiotic for pneumonia 156 177 0.328 0.052 6.273 < 0.001a
aSignificant value within 95 % confidence intervals
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which account for many possible confounders but for
which the risk of selection bias often remains [26]. Efforts
were made to include all necessary variables affecting
programme selection available in the dataset to mitigate
bias. A sensitivity analysis was also done to see how the
results would be affected by varying levels of bias. Although
sample size calculations were based on a representative
sample, there were inevitable limitations of using household
survey data for equity analysis [32]. For example there were
small samples sizes in some sub-populations such as the
proportion of children receiving zinc for diarrhoea, which
prevented further meaningful analysis.
Conclusion
In view of limited human resources for health, large scale
implementation of CHWs delivering integrated child health
services could lead to significant gains in the proportion of
sick children receiving appropriate treatment. Yet careful
consideration of the common challenges CHWs face deliv-
ering high quality care in an isolated rural environment is
needed, especially to address lack of supervision and drug
supply, which negatively affect CHW performance and
subsequently programme outputs [12, 33–35]. There is also
a need to implement and evaluate simple interventions that
can increase uptake of zinc, like co-packaging of ORS with
zinc, as these might serve to improve overall uptake of
effective diarrhoeal treatments [31].
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